Clinical Trials Directory

Trials / Completed

CompletedNCT00356850

Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers

Ocular Pharmacokinetics After a Single Drop Instillation, in Each Eye of One of Three Different Concentrations of T1225 (0.5% - 1% - 1.5% Dihydrate) in 91 Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
Sponsor
Laboratoires Thea · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

To evaluate azithromycin tear concentrations after instillation of one drop of one of the three T1225 concentrations (0.5%, 1% and 1.5%) and to evaluate the ocular safety.

Detailed description

The aim of the present study was to compare azithromycin tear ocular concentrations after a single instillation of three different T1225 concentrations in order to determine early azithromycin tear concentration and to assess the T1225 concentration, which allowed having the higher azithromycin tear concentration, 24 hours after a single instillation.

Conditions

Interventions

TypeNameDescription
DRUGAzithromycin

Timeline

Start date
2002-05-01
Completion
2002-06-01
First posted
2006-07-26
Last updated
2006-07-26

Source: ClinicalTrials.gov record NCT00356850. Inclusion in this directory is not an endorsement.

Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers (NCT00356850) · Clinical Trials Directory